Breaking News

Ajinomoto Completes Althea Acquisition

April 5, 2013

Will operate under the name Ajinomoto Althea

Ajinomoto Co., Inc. has completed its acquisition of Althea Technologies, a provider of biopharmaceutical development and manufacturing services, for approximately $175 million. Althea will become a fully consolidated subsidiary of Ajinomoto Co. operating under the company name Ajinomoto Althea, Inc.
blog comments powered by Disqus
  • Quality Risk Management

    Quality Risk Management

    Cheryl Abernathy and Bryan Sasbon, Quality Assurance Operations Manager, Ropack Pharma Solutions; QA Director & Regulatory Affairs, Ropack Pharma Solutions||September 8, 2016
    Embracing the process as a means to a strong quality culture

  • Staying Ahead in the Small Molecule Space

    Staying Ahead in the Small Molecule Space

    Dr. Matthew Moorcroft, VP Global Marketing, Cambrex||September 8, 2016
    Understand what is happening in the market and react accordingly

  • FDA & Drug Development

    FDA & Drug Development

    Rachelle Du2019Souza, Regulatory Heights Inc.||September 8, 2016
    You must perform the necessary due diligence to stay on top of regulatory developments